T20	Exp 402 419	the CXC chemokine
T21	Exp 332 347	This phenomenon
T22	Exp 458 460	we
T23	Exp 473 481	the role
T24	Exp 446 456	this study
T25	Exp 763 773	the effect
T26	Exp 795 807	the presence
T27	Exp 882 899	the IL-8 promoter
T28	Exp 953 1006	the 65 kD transcriptional activator NF-kappaB subunit
T29	Exp 1032 1043	the nucleus
T30	Exp 1163 1197	the antioxidant dimethyl sulfoxide
T31	Exp 1406 1455	the unrelated antioxidants, N-acetylcysteine (NAC
T32	Exp 1655 1680	its nuclear translocation
T33	Exp 1492 1496	that
T34	Exp 1557 1561	that
T35	Exp 1472 1482	These data
T36	Exp 1704 1716	this pathway
R3	Coref Anaphora:T34 Antecedent:T37
R4	Coref Anaphora:T32 Antecedent:T18
T1	Protein 45 58	interleukin-8
T2	Protein 78 105	tumor necrosis factor alpha
T3	Protein 202 229	Tumor necrosis factor alpha
T4	Protein 231 239	TNFalpha
T5	Protein 421 434	interleukin-8
T6	Protein 436 440	IL-8
T7	Protein 485 493	TNFalpha
T8	Protein 537 541	IL-8
T9	Protein 605 613	TNFalpha
T10	Protein 638 642	IL-8
T11	Protein 777 785	TNFalpha
T12	Protein 859 864	Rel A
T13	Protein 886 890	IL-8
T14	Protein 901 909	TNFalpha
T15	Protein 1008 1013	Rel A
T16	Protein 1149 1157	TNFalpha
T17	Protein 1324 1329	Rel A
T18	Protein 1497 1505	TNFalpha
T19	Protein 1772 1780	TNFalpha
T37	Exp 1514 1556	a delayed ROS-dependent signalling pathway
